Results 181 to 190 of about 125,515 (216)

Resistant Hypertension Treated With Extravascular Renal Denervation. [PDF]

JACC Case Rep
Park H, Hwang EC, Jo JK, Shin JH, Lim YH, Jeong CW, Shin J.   +6 more
europepmc   +1 more source

Syncing Health Timing: Exploring the Interplay of Circadian Rhythms, Obesity, and Cardiovascular Diseases

Food Safety and Health, EarlyView.
Circadian rhythm disruption impairs metabolic regulation, appetite control, and vascular function, promoting obesity and cardiovascular diseases. Evidence highlights a bidirectional relationship where metabolic disorders further disturb circadian timing.
Ghizal Fatima, István Dalmadi, Anna Jánosi, Krisztina Takács, Eszter Halmy   +4 more
wiley   +1 more source

The association of urinary sodium with incident apparent treatment resistant hypertension among African Americans: findings from the Jackson Heart Study. [PDF]

J Hum Hypertens
Sanuade OA, Addo DK, Smith JD, Carroll AJ, Shimbo D, Talegawkar S, Tucker KL, Jacobs JA, Derington CG, Bress AP.   +9 more
europepmc   +1 more source

A Pharmacogenomics‐Guided Antihypertensive Strategy for Blood Pressure Reduction in Rural China: A Cluster‐Randomized Controlled Trial

Health Care Science, EarlyView.
This manuscript reports the findings from the Pharmacogenomic‐guided Antihypertensive Strategy Trial study amidst the deteriorating blood pressure control observed globally during the COVID‐19 pandemic. A pharmacogenomics‐guided strategy achieved a 98.4% blood pressure control rate at 4 weeks in rural China.
Wangjun Qin, Mengke Yu, Ying Zhu, Queran Lin, Limei Yin, Guisheng Liu, Yaping Wang, Guangqiang Lu, Xiaofei Liu, Pengmei Li, Xudong Kong, Li Zhao, Kun Tang, Jiangli Jin, Yu Xiong, Yingnan Zhao, Yan Yan, Bo Li, Azeem Majeed, Xianbo Zuo, Yue Qiu, Jiantuo Yu, Lihong Liu   +22 more
wiley   +1 more source

Incidence and prognosis of apparent-treatment resistant hypertension: a multi-state analysis using real world evidence. [PDF]

Clin Hypertens
Teza H, Anothaisintawee T, Limpijankit T, Tansawet A, Boonmanunt S, Pattanateepapon A, McKay GJ, Attia J, Thakkinstian A.   +8 more
europepmc   +1 more source

Efficacy of L-methylfolate and methylcobalamin in treating resistant hypertension associated with elevated serum homocysteine in hemodialysis patients. [PDF]

BMC Nephrol
Salem MS, Hamdy NA, Elghoneimy HA, El Gowelli HM.   +3 more
europepmc   +1 more source

Primary care provider's barriers to effective management of apparently resistant hypertension in Malaysian public primary health care and strategies to overcome them: a qualitative study. [PDF]

BMC Prim Care
Elias R, Mustapha M, Omar J, Kana K, Lukas S, Brohi IB, Liu YC, Ooi CY.   +7 more
europepmc   +1 more source

Efficacy and safety of a modified ozone-mediated neurolysis in treatment for patients with resistant hypertension. [PDF]

Hypertens Res
Zhang L, Huang B, Zhang Y, Zeng F, Tian P, Li B, Chen X, Wang J, Huang Y, Li L.   +9 more
europepmc   +1 more source

Acetate concentration correlates with MSNA in patients with resistant hypertension. [PDF]

Clin Auton Res
Carnagarin R, Sesa-Ashton G, Ward NC, Nolde J, Joyson A, Chan J, Jose A, Schlaich MP.   +7 more
europepmc   +1 more source

Efficacy and safety of extravascular renal denervation in patients with resistant hypertension: a study protocol for a pilot, single-arm, multi-center, first-in-human study. [PDF]

Clin Hypertens
Yoon M, Kim HK, Han JH, Kim HJ, Jeong CW, Choi DJ.   +5 more
europepmc   +1 more source